Facilities and Equipment is a very broad track intended to challenge those involved in the delivery of pharmaceutical facilities used to support the development, manufacturing, testing, and storage of pharmaceutical industry products meeting quality standards, employing efficient design, project delivery strategies, and adopting sustainable approaches to meet environmental expectations. The 2018 ISPE Annual Meeting & Expo Facilities Equipment Track will include industry owners, industry supplier experts, and innovators ready to share best practices and new approaches to advance efficiencies in the pharmaceutical manufacturing sector.
This year’s topics will address those areas that are currently challenging those who specify, design, and build our manufacturing plants including:
Facilities and Equipment Track session leaders and speakers have put together a program of case studies, industry surveys, practical experience, and forward-thinking strategies. Sessions include:
I look forward to meeting you in Philadelphia this November at the 2018 ISPE Annual Meeting & Expo – come join us as we examine ways to achieve efficiencies in manufacturing.
In the pharmaceutical industry, which is highly regulated, aseptic processing is a critical component that ensures the sterility of products. Regulators have a set of comprehensive requirements that minimize the risk of contamination. Regulators set the requirements; however, the industry has an obligation to the patients who rely on and expect a drug that is safe and free of contamination....
Like any investment in digital manufacturing systems, demonstrating business payback before and after investment is critical to getting MES projects approved and verifying profitability after investment. Whether it is introducing MES, expanding it to additional sites, switching software, upgrading existing software, or developing electronic production records (EPR) for new drug products,...
Sustainability is emerging as a pivotal force influencing the pharmaceutical industry’s dynamics and steering companies towards transformative change. The focus of this analysis is to delve into the sustainability key performance indicators (KPIs) of prominent pharmaceutical players, namely Pfizer, Sanofi, Glaxo Smith Kline (GSK), Becton Dickinson, Johnson & Johnson, Abbott, Eli Lilly, and...